European healthcare systems are under constant pressure to contain healthcare expenditure. Understanding future drug expenditure is an important consideration for payers when formulating policies. QuintileIMS publishes European forecasts that are underpinned by its audited volume data and publicly available list prices. With increasing price pressures, list to net price divergence is growing, although some of this information is commercially sensitive and thus not publicly available. The objective of this study was to further develop an established forecast to account for this divergence and explore its impact.
|Number of pages||1|
|Publication status||Accepted/In press - 7 Aug 2017|
|Event||ISPOR 20th Annual European Congress - Glasgow, United Kingdom|
Duration: 4 Nov 2017 → 8 Nov 2017
Conference number: 20th
|Conference||ISPOR 20th Annual European Congress|
|Period||4/11/17 → 8/11/17|
- European healthcare
- healthcare expenditure
Espin, J., Schlander, M., Godman, B., Anderson, P., Mestre-Ferrandiz, J., Hutchings, A., Flostrand, S., & Parnaby, A. (Accepted/In press). Forecasting pharmaceutical expenditure in Europe: adjusting for the impact of rebates and discounts. Abstract from ISPOR 20th Annual European Congress, Glasgow, United Kingdom.